Literature DB >> 16479008

Regulation of sprouty stability by Mnk1-dependent phosphorylation.

John DaSilva1, Lizhong Xu, Hong Joo Kim, W Todd Miller, Dafna Bar-Sagi.   

Abstract

Sprouty (Spry) proteins are negative feedback modulators of receptor tyrosine kinase pathways in Drosophila melanogaster and mammals. Mammalian Spry proteins have been shown to undergo tyrosine and serine phosphorylation in response to growth factor stimulation. While several studies have addressed the function of tyrosine phosphorylation of Spry, little is known about the significance of Spry serine phosphorylation. Here we identify mitogen-activated protein kinase-interacting kinase 1 (Mnk1) as the kinase that phosphorylates human Spry2 (hSpry2) on serines 112 and 121. Mutation of these serine residues to alanine or inhibition of Mnk1 activity increases the rate of ligand-induced degradation of hSpry2. Conversely, enhancement of serine phosphorylation achieved through either the inhibition of cellular phosphatases or the expression of active Mnk1 results in the stabilization of hSpry2. Previous studies have shown that growth factor stimulation induces the proteolytic degradation of hSpry2 by stimulating tyrosine phosphorylation on hSpry2, which in turn promotes c-Cbl binding and polyubiquitination. A mutant of hSpry2 that is deficient in serine phosphorylation displays enhanced tyrosine phosphorylation and c-Cbl binding, indicating that serine phosphorylation stabilizes hSpry2 by exerting an antagonistic effect on tyrosine phosphorylation. Moreover, loss of serine phosphorylation and the resulting enhanced degradation of hSpry2 impair its capacity to antagonize fibroblast growth factor-induced extracellular signal-regulated kinase activation. Our results imply that Mnk1-mediated serine phosphorylation of hSpry2 constitutes a regulatory mechanism to extend the temporal range of Spry activity.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16479008      PMCID: PMC1430244          DOI: 10.1128/MCB.26.5.1898-1907.2006

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  66 in total

Review 1.  Cell signaling by receptor tyrosine kinases.

Authors:  J Schlessinger
Journal:  Cell       Date:  2000-10-13       Impact factor: 41.582

Review 2.  Keeping the receptor tyrosine kinase signaling pathway in check: lessons from Drosophila.

Authors:  Ilaria Rebay
Journal:  Dev Biol       Date:  2002-11-01       Impact factor: 3.582

3.  Sprouty1 and Sprouty2 provide a control mechanism for the Ras/MAPK signalling pathway.

Authors:  Hiroshi Hanafusa; Satoru Torii; Takayuki Yasunaga; Eisuke Nishida
Journal:  Nat Cell Biol       Date:  2002-11       Impact factor: 28.824

4.  Reduced MAP kinase phosphatase-1 degradation after p42/p44MAPK-dependent phosphorylation.

Authors:  J M Brondello; J Pouysségur; F R McKenzie
Journal:  Science       Date:  1999-12-24       Impact factor: 47.728

5.  Serine 727 phosphorylation and activation of cytosolic phospholipase A2 by MNK1-related protein kinases.

Authors:  Y Hefner; A G Borsch-Haubold; M Murakami; J I Wilde; S Pasquet; D Schieltz; F Ghomashchi; J R Yates; C G Armstrong; A Paterson; P Cohen; R Fukunaga; T Hunter; I Kudo; S P Watson; M H Gelb
Journal:  J Biol Chem       Date:  2000-12-01       Impact factor: 5.157

Review 6.  Negative regulation of receptor tyrosine kinases: unexpected links to c-Cbl and receptor ubiquitylation.

Authors:  Chanan Rubin; Gal Gur; Yosef Yarden
Journal:  Cell Res       Date:  2005-01       Impact factor: 25.617

7.  A misexpression screen identifies genes that can modulate RAS1 pathway signaling in Drosophila melanogaster.

Authors:  A M Huang; G M Rubin
Journal:  Genetics       Date:  2000-11       Impact factor: 4.562

8.  Sprouty2 attenuates epidermal growth factor receptor ubiquitylation and endocytosis, and consequently enhances Ras/ERK signalling.

Authors:  Esther Sook Miin Wong; Chee Wai Fong; Jormay Lim; Permeen Yusoff; Boon Chuan Low; Wallace Y Langdon; Graeme R Guy
Journal:  EMBO J       Date:  2002-09-16       Impact factor: 11.598

9.  The Drosophila protein kinase LK6 is regulated by ERK and phosphorylates the eukaryotic initiation factor eIF4E in vivo.

Authors:  Josep L Parra-Palau; Gert C Scheper; Daniel E Harper; Christopher G Proud
Journal:  Biochem J       Date:  2005-02-01       Impact factor: 3.857

10.  mSprouty2 inhibits FGF10-activated MAP kinase by differentially binding to upstream target proteins.

Authors:  D Tefft; M Lee; S Smith; D L Crowe; S Bellusci; D Warburton
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2002-10       Impact factor: 5.464

View more
  33 in total

1.  Bimodal expression of Sprouty2 during the cell cycle is mediated by phase-specific Ras/MAPK and c-Cbl activities.

Authors:  Christoph-Erik Mayer; Barbara Haigl; Florian Jantscher; Gerald Siegwart; Michael Grusch; Walter Berger; Hedwig Sutterlüty
Journal:  Cell Mol Life Sci       Date:  2010-05-12       Impact factor: 9.261

Review 2.  Receptor tyrosine kinase (RTK) signalling in the control of neural stem and progenitor cell (NSPC) development.

Authors:  Alexander Annenkov
Journal:  Mol Neurobiol       Date:  2013-08-28       Impact factor: 5.590

3.  HECT domain-containing E3 ubiquitin ligase Nedd4 interacts with and ubiquitinates Sprouty2.

Authors:  Francis Edwin; Kimberly Anderson; Tarun B Patel
Journal:  J Biol Chem       Date:  2009-10-28       Impact factor: 5.157

4.  Combined deficiency for MAP kinase-interacting kinase 1 and 2 (Mnk1 and Mnk2) delays tumor development.

Authors:  Takeshi Ueda; Masato Sasaki; Andrew J Elia; Iok In Christine Chio; Koichi Hamada; Rikiro Fukunaga; Tak W Mak
Journal:  Proc Natl Acad Sci U S A       Date:  2010-08-02       Impact factor: 11.205

5.  Sprouty proteins are negative regulators of interferon (IFN) signaling and IFN-inducible biological responses.

Authors:  Bhumika Sharma; Sonali Joshi; Antonella Sassano; Beata Majchrzak; Surinder Kaur; Priya Aggarwal; Behnam Nabet; Marinka Bulic; Brady L Stein; Brandon McMahon; Darren P Baker; Rikiro Fukunaga; Jessica K Altman; Jonathan D Licht; Eleanor N Fish; Leonidas C Platanias
Journal:  J Biol Chem       Date:  2012-10-16       Impact factor: 5.157

6.  A SPRY2 mutation leading to MAPK/ERK pathway inhibition is associated with an autosomal dominant form of IgA nephropathy.

Authors:  Annamaria Milillo; Francesca La Carpia; Stefano Costanzi; Vanessa D'Urbano; Maurizio Martini; Paola Lanuti; Gisella Vischini; Luigi M Larocca; Marco Marchisio; Sebastiano Miscia; Antonio Amoroso; Fiorella Gurrieri; Eugenio Sangiorgi
Journal:  Eur J Hum Genet       Date:  2015-03-18       Impact factor: 4.246

7.  Sprouty2-mediated inhibition of fibroblast growth factor signaling is modulated by the protein kinase DYRK1A.

Authors:  Sergi Aranda; Mónica Alvarez; Silvia Turró; Ariadna Laguna; Susana de la Luna
Journal:  Mol Cell Biol       Date:  2008-08-04       Impact factor: 4.272

8.  Mnk Kinases in Cytokine Signaling and Regulation of Cytokine Responses.

Authors:  Sonali Joshi; Leonidas C Platanias
Journal:  Biomol Concepts       Date:  2012-04

9.  Argonaute-2 expression is regulated by epidermal growth factor receptor and mitogen-activated protein kinase signaling and correlates with a transformed phenotype in breast cancer cells.

Authors:  Brian D Adams; Kevin P Claffey; Bruce A White
Journal:  Endocrinology       Date:  2008-09-11       Impact factor: 4.736

10.  Sprouty2 association with B-Raf is regulated by phosphorylation and kinase conformation.

Authors:  Suzanne C Brady; Mathew L Coleman; June Munro; Stephan M Feller; Nicolas A Morrice; Michael F Olson
Journal:  Cancer Res       Date:  2009-08-18       Impact factor: 12.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.